CIGB-370 administration in malignant tumors . Repeated dose study, dose escalation.
Latest Information Update: 16 Oct 2020
At a glance
- Drugs CIGB 370 (Primary)
- Indications Solid tumours; Tumours
- Focus Adverse reactions
- Acronyms POLITUR-2
- 04 Nov 2019 Planned number of patients changed from 24 to 18.
- 04 Nov 2019 Status changed from not yet recruiting to completed.
- 29 Aug 2016 New trial record